Shield Therapeutics submits NDA in US for Feraccru to treat iron deficiency

Image: In Switzerland, Feraccru has been approved to treat iron deficiency anaemia in adults having inflammatory bowel disease. Photo: courtesy of Thought Catalog on Unsplash.